Tag: therapy option
BDR Receives DCGI Approval for Favipiravir to Treat COVID-19
MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.
MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.